Cad is brí le “Soiléir”?
Ní iompraíonn an t-ainmhí an sóchán. Ní dhéanfaidh sé an galar a fhorbairt agus ní chuirfidh sé ar aghaidh é.
The Cardiomyopathy With Juvenile Mortality (CJM) DNA test in dogs is essential for early detection of this hereditary heart condition. CJM causes severe heart muscle disease leading to sudden death in young dogs, making genetic screening crucial for breeders and pet owners. By identifying carriers and affected dogs, the CJM DNA test helps prevent the spread of this fatal disorder within breeding lines. Early diagnosis through this test allows for better management and care of at-risk dogs. Reliable and accurate, the CJM DNA test supports responsible breeding practices and promotes healthier canine populations. Ensure your dog’s health and future by opting for the Cardiomyopathy With Juvenile Mortality DNA test today. Protect your pet with advanced genetic testing designed to save lives.
The DNA test for Cardiomyopathy With Juvenile Mortality (CJM) in dogs helps identify carriers of this genetic condition. CJM is a serious heart disease that can cause sudden death in young dogs. Early detection through testing allows breeders to make informed decisions and reduce the risk of passing the mutation to offspring. This test is especially important for breeds known to be affected by CJM. Responsible breeding based on DNA results promotes healthier future generations of dogs.
Tá an tástáil DNA seo san áireamh ag tosú ónár bpacáiste Basic — agus tá sé mar chuid de na pacáistí freisin Basic, Standard, Advanced, Complete.
Féach ar Pacáistí Tástála DNA →Cardiomyopathy With Juvenile Mortality (CJM) is a serious and often fatal heart condition that primarily affects young dogs. It is characterized by the degeneration of heart muscle, leading to impaired heart function and, in severe cases, sudden cardiac death. CJM typically presents in dogs under the age of two, making early detection and intervention crucial for improving outcomes.
The underlying cause of CJM involves genetic mutations that disrupt the normal structure and function of cardiac muscle cells. As the disease progresses, the heart becomes progressively weaker, resulting in decreased cardiac output and potential rhythm disturbances. These changes can lead to symptoms such as lethargy, weakness, and exercise intolerance, which may rapidly escalate to life-threatening conditions.
Dogs affected by CJM may exhibit a range of clinical signs, including coughing, difficulty breathing, and fainting episodes. Due to the rapid progression of the disease, it is essential for pet owners to seek veterinary attention promptly if they notice any concerning symptoms. Diagnosis typically involves a combination of physical examinations, echocardiography, and electrocardiograms to assess heart function and identify abnormalities.
While there is currently no cure for CJM, management strategies aim to improve the quality of life and prolong survival for affected dogs. Treatment may include medications to support heart function, reduce fluid buildup, and manage arrhythmias. Additionally, lifestyle modifications, such as restricted exercise and regular veterinary check-ups, play an important role in managing the condition effectively.
Genetic testing for CJM is a valuable tool for identifying at-risk dogs and guiding breeding decisions. By understanding the genetic predisposition to this condition, breeders can make informed choices to reduce the incidence of CJM in future generations. Furthermore, early identification of affected individuals allows for timely intervention and better management of the disease.
Cardiomyopathy With Juvenile Mortality (CJM) represents a significant health concern in young dogs, emphasizing the importance of awareness, early detection, and genetic testing. By recognizing the signs of this condition and seeking appropriate veterinary care, pet owners can help ensure their dog's health and well-being. Ongoing research and advancements in genetic testing continue to provide hope for better management and prevention strategies for CJM.
Ní iompraíonn an t-ainmhí an sóchán. Ní dhéanfaidh sé an galar a fhorbairt agus ní chuirfidh sé ar aghaidh é.
Tá an t-ainmhí sláintiúil go ginearálta ach is féidir leis an sóchán a tharchur chuig a sliocht.
Tá dhá chóip mutated ar iompar aige. Táthar ag súil le comharthaí cliniciúla ag brath ar an galar. Níor chóir é a phóraítear.
Tá roinnt galair ceangailte le gnéas, mar sin athraíonn a léiriú ag brath ar an gnéas ainmhí.
This DNA test detects the mutation associated with Cardiomyopathy With Juvenile Mortality (CJM) in order to identify clear, carrier, or at-risk animals.
Cuidíonn tástáil DNA le póraitheoirí cúplála níos sábháilte a phleanáil agus an baol go dtarchuirfear an sóchán chuig an sliocht a laghdú.
Is é Autosomal Recessive an modh oidhreachta a thuairiscítear don tástáil seo.
This test analyses the mutation YARS2 c.1054G>A.
Ní gá. Braitheann an léirmhíniú ar an bpatrún oidhreachta agus ar an géinitíopa dá bharr.
Gurtner Corinne, Hug Petra, Kleiter Miriam, Köhler Kernt, Dietschi Elisabeth, Jagannathan Vidhya, Leeb Tosso. YARS2 Missense Variant in Belgian Shepherd Dogs with Cardiomyopathy and Juvenile Mortality. Genes (Basel). 2020 Mar 14;11(3):313. doi: 10.3390/genes11030313.
Do phríobháideachas, do rogha
Bainimid úsáid as fianáin riachtanacha chun an suíomh Gréasáin a rith. Díchumasaítear fianáin roghnacha (cosúil le soláthraithe ábhair leabaithe) de réir réamhshocraithe agus ní chuirtear ar chumas iad ach amháin má aontaíonn tú. Is féidir leat do rogha a athrú am ar bith agus an cnaipe “Fianáin” á úsáid agat.
Ag teastáil le haghaidh gnéithe lárnacha agus slándála. Cumasaithe i gcónaí.
Feabhsaítear gnéithe mar shábháil tosaíochta nó leabaithe neamhfhógraíochta.
Cuidíonn sé linn úsáid láithreáin a thuiscint. Díchumasaithe de réir réamhshocraithe.
Fógraíocht/rianú trasna suíomhanna (leabaíonn roinnt fístéipeanna/léarscáileanna). Díchumasaithe de réir réamhshocraithe.